Article thumbnail

Inhibition of full length Hepatitis C Virus particles of 1a genotype through small interference RNA

By Muhammad Ansar, Usman Ali Ashfaq, Imran shahid, Muhammad Tahir Sarwar, Tariq Javed, Sidra Rehman, Sajida Hassan and Sheikh Riazuddin
Topics: Research
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:3094304
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2002). Agami R: A system for stable expression of short interfering RNAs in mammalian cells. Science
  2. (2007). al: Cellular cofactors affecting hepatitis C virus infection and replication. Proc Natl Acad Sci USA
  3. (2001). Albrecht JK: Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet
  4. (2003). Approaches for the sequence-specific knockdown of mRNA.
  5. (2005). Barik S: Inhibition of respiratory viruses by nasally administered siRNA. Nat Med
  6. (1998). CC: Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans.
  7. (2005). CD: Hepatitis C virus replicons escape RNA interference induced by a short interfering RNA directed against the NS5b coding region.
  8. (2003). CD: RNA interference blocks gene expression and RNA synthesis from hepatitis C replicons propagated in human liver cells. Proc Natl Acad Sci USA
  9. (1994). CM: Processing in the hepatitis C virus E2-NS2 region: identification of p7 and two distinct E2-specific products with different C termini.
  10. (2007). DV: Antisense technology: a selective tool for gene expression regulation and gene targeting. Curr Pharm Biotechnol
  11. (2006). et al: HepG2 cells support viral replication and gene expression of hepatitis C virus genotype 4 in vitro.
  12. (2002). et al: Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
  13. (2007). Fausto N: Hepatitis C virus replication in transfected and serum-infected cultured human fetal hepatocytes.
  14. (2003). FV: Interference of hepatitis C virus RNA replication by short interfering RNAs.
  15. (2005). FV: Robust hepatitis C virus infection in vitro.
  16. (2004). Health Organization. Department of Measurement and Health Information.
  17. (2009). HM: Consensus siRNA for inhibition of HCV genotype-4 replication. Virol J
  18. (2002). Hoofnagle JH: Optimal therapy of hepatitis C. Hepatology
  19. (2001). Horie T, et al: Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis. Cancer Res
  20. (2004). Hotta H: Suppression of hepatitis C virus replicon by RNA interference directed against the NS3 and NS5B regions of the viral genome. Microbiol Immunol
  21. (2006). Inhibition of hepatitis C virus gene expression by small interfering RNAs using a tri-cistronic full-length viral replicon and a transient mouse model. Virus Res
  22. (2003). Inhibition of intracellular hepatitis C virus replication by synthetic and vector-derived small interfering RNAs. EMBO Rep
  23. (1989). Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science
  24. (2007). Liver target delivery of small interfering RNA to the HCV gene by lactosylated cationic liposome.
  25. (2002). MA: RNA interference in adult mice. Nature
  26. (2002). Memon MA: Hepatitis C: an epidemiological review.
  27. (2006). of 6antiviral activity of interferon against hepatitis C virus infection. Gastroenterology
  28. (2009). Optimization of linear doublestranded RNA for the production of multiple siRNAs targeting hepatitis C virus. Rna
  29. (2001). RA: Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems.
  30. (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.
  31. (1997). Regulated processing of hepatitis C virus core protein is linked to subcellular localization.
  32. (2000). Rice CM: Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties. Curr Top Microbiol Immunol
  33. (2001). RNA interference and small interfering RNAs. Chembiochem
  34. (2001). RNA interference–2001. Genes Dev
  35. (2002). RNA interference: antiviral defense and genetic tool. Nat Immunol
  36. (2002). RNA interference.
  37. S: RNAi as a new therapeutic strategy against HCV.
  38. (2005). Small interfering RNA effectively inhibits protein expression and negative strand RNA synthesis from a full-length hepatitis C virus clone.
  39. (2003). Small interfering RNAmediated inhibition of hepatitis C virus replication in the human hepatoma cell line Huh-7. J Virol
  40. (2001). Tuschl T: Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature
  41. (2001). Tuschl T: Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate. Embo J
  42. (2001). Tuschl T: RNA interference is mediated by 21-and 22-nucleotide RNAs. Genes Dev
  43. (2006). ZT: RNA interference effectively inhibits mRNA accumulation and protein expression of hepatitis C virus core and E2 genes in human cells. Biosci Biotechnol Biochem